
In 2016, after a series of journalistic and regulatory investigations that questioned the veracity of Theranos' claims, federal prosecutors began criminal investigations for potentially misleading investors and the government about the company's blood-testing technology.
Pages:
1 2 3 4 5 6 7 8 9 10